and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. Today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO. Dr. Pad ...

“Arcturus has deep expertise in mRNA delivery for therapeutics and a validated commercial stage vaccines platform,” said Dr. Moncef Slaoui. “I am excited to work with the company during this ...

"Arcturus continues to make excellent progress ... Ph.D., as Chair Designate. Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024.

Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024. Arcturus’ primary revenue streams include license fees, consulting and related technology ...